Australia TGA ARTG recordSevere acute respiratory syndrome-associated coronavirus IVDs
Australia TGA ARTG Registered Device · Qiagen Pty Ltd · Qiagen GmbH · Class IIb · Started December 08, 2023
Good Name: Qiagen Pty Ltd - Severe acute respiratory syndrome-associated coronavirus IVDs
- Risk Class
- Class IIb
- Product Type
- IVD
- ARTG Category
- IVD
- Start Date
- December 08, 2023
- Effective Date
- December 08, 2023
- Name
- Qiagen Pty Ltd
- Name
- Qiagen GmbH
- Country
- Germany
- Address
- Qiagen Str 1, Hilden, 40724
IVDs for the qualitative detection of nucleic acid from SARS-CoV-2 in human clinical specimens
Access comprehensive regulatory information for Severe acute respiratory syndrome-associated coronavirus IVDs in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class IIb is sponsored by Qiagen Pty Ltd, manufactured by Qiagen GmbH in Germany. The device registration started on December 08, 2023.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.